Sernova Biotherapeutics (SVA.TO) Q4 2025 Earnings

19DecConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.02
-0.02
-0.01
-0.01

Details

Expected EPS
-0.009844919999999998
Actual EPS
-0.0053162567999999995
Surprise EPS
0
Surprise Percent
+46%

Description

Sernova Biotherapeutics (SVA.TO) has reported earnings of -0.0053162567999999995 per share for Q4 2025.

0 Comments

Share your thoughts